Skip to main content

Table 3 In-hospital outcomes

From: Risk factors associated with acute kidney injury in a cohort of hospitalized patients with COVID-19

Characteristics

Total (n = 1,584)

No AKI (n = 846)

AKI (n = 738)

p-value

Vasopressor support during hospitalization—n (%)

545 (34.3)

129 (15.3)

416 (56.4)

 < 0.001

Mechanical ventilation during hospitalization—n (%)

620 (39.1)

170 (20.1)

450 (61)

 < 0.001

ICU admission—n (%)

690 (43.6)

216 (25.5)

474 (64.2)

 < 0.001

Mean hospitalization—days (IQR)

10 (12)

8 (9)

14 (15)

 < 0.001

Renal replacement therapy modalities n (%)

  

82 (11.1%)

 

Peritoneal dialysis

  

1 (1.2%)

 

Intermittent hemodialysis

  

27 (32.9%)

 

CRRT

  

54 (65.8%)

 

Infection acquired during hospitalization—n (%)

263 (16.6)

74 (8.7)

189 (25.6)

 < 0.001

 Bloodstream infection—n (%)

49 (3.1)

15 (1.8)

34 (4.6)

 < 0.001

 Urinary tract infection—n (%)

41 (2.6)

12 (1.4)

29 (3.9)

0.002

 Healthcare-associated pneumonia—n (%)

80 (5.1)

18 (2.1)

62 (8.4)

 < 0.001

 Infection of the operative site—n (%)

1 (0.06)

0 (0)

1 (0.14)

0.284

 Another infection during hospitalization—n (%)

92 (5.8)

29 (3.4)

63 (8.5)

 < 0.001

 Intrahospital mortality—n (%)

435 (27.5)

99 (11.7)

336 (45.5)

 < 0.001

  1. AKI Acute kidney injury, ICU Intensive care unit, CRRT Continuous Renal replacement therapy